Citation Impact
Citing Papers
Impact of Aortic Valve Replacement on Outcome of Symptomatic Patients With Severe Aortic Stenosis With Low Gradient and Preserved Left Ventricular Ejection Fraction
2013
Risk Score for Predicting Outcome in Patients With Asymptomatic Aortic Stenosis
2009
Effect of Lipid Lowering With Rosuvastatin on Progression of Aortic Stenosis
2010
A sex-biased imbalance between Tfr, Tph, and atypical B cells determines antibody responses in COVID-19 patients
2023 StandoutNobel
Conserved N-terminal cysteine dioxygenases transduce responses to hypoxia in animals and plants
2019 StandoutScienceNobel
Early Surgery Versus Conventional Treatment in Asymptomatic Very Severe Aortic Stenosis
2010
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
2009
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Haemodynamic definitions and updated clinical classification of pulmonary hypertension
2018 Standout
Early Surgery or Conservative Care for Asymptomatic Aortic Stenosis
2019
β-Arrestin-2 Mediates Anti-apoptotic Signaling through Regulation of BAD Phosphorylation
2009 StandoutNobel
Molecular and cellular mechanisms of the thrombotic complications of atherosclerosis
2008
Hypoxia-Inducible Factors in Physiology and Medicine
2012 StandoutNobel
Tadalafil Therapy for Pulmonary Arterial Hypertension
2009 Standout
Predictors of outcome in patients with severe aortic stenosis and normal left ventricular function: role of B-type natriuretic peptide
2004
Therapy for Pulmonary Arterial Hypertension in Adults
2019
Antithrombotic Therapy for Venous Thromboembolic Disease
2008 Standout
Unequal impact of age, percentage body fat, and serum testosterone concentrations on the somatotrophic, IGF-I, and IGF-binding protein responses to a three-day intravenous growth hormone-releasing hormone pulsatile infusion in men
1998
Left ventricular systolic and diastolic function assessed by tissue Doppler imaging and outcome in asymptomatic aortic stenosis
2010
Review: Hemodynamic Characteristics and Outcomes of Sickle Cell Disease Associated Pulmonary Hypertension
2016
Growth Hormone, Exercise, and Aging: The Future of Therapy for the Frail Elderly
1994
Clopidogrel with or without Omeprazole in Coronary Artery Disease
2010 Standout
A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis
2003
Should coronary artery bypass graft surgery patients with mild or moderate aortic stenosis undergo concomitant aortic valve replacement?
2004
Valvular Aortic Stenosis
2006
Management of mild aortic stenosis in patients undergoing coronary bypass surgery
2001
The role of B cells in atherosclerosis
2018
Aortic complications after bicuspid aortic valve replacement: long-term results
2002
Effect of galanin on growth hormone-releasing hormone-stimulated growth hormone secretion in adult patients with nonendocrine diseases on long-term daily glucocorticoid treatment
1992
Association of cholesterol levels, hydroxymethylglutaryl coenzyme-a reductase inhibitor treatment, and progression of aortic stenosis in the community
2002
Treatment of Pulmonary Arterial Hypertension
2004 Standout
Recommendations on the Echocardiographic Assessment of Aortic Valve Stenosis: A Focused Update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography
2017
Usefulness of exercise-stress echocardiography for risk stratification of true asymptomatic patients with aortic valve stenosis
2010
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008
Risk stratification in asymptomatic severe aortic stenosis: a critical appraisal
2012
Cushing's syndrome
2015 Standout
Definitions and Diagnosis of Pulmonary Hypertension
2013 Standout
Antithrombotic Therapy for VTE Disease
2016 Standout
Outcomes in Adults With Bicuspid Aortic Valves
2008
Effects of Progestin-Opposed Transdermal Estrogen Administration on Growth Hormone and Insulin-Like Growth Factor-I in Postmenopausal Women of Different Ages*
1991
Changes in size of ascending aorta and aortic valve function with time in patients with congenitally bicuspid aortic valves
2003
Calcineurin Promotes Hypoxia-inducible Factor 1α Expression by Dephosphorylating RACK1 and Blocking RACK1 Dimerization
2007 StandoutNobel
Updated Clinical Classification of Pulmonary Hypertension
2009 Standout
Chronic thromboembolic pulmonary hypertension
2018
Improvement of tricuspid regurgitation after pulmonary thromboendarterectomy
2002
Prognosis of Severe Asymptomatic Aortic Stenosis With and Without Surgery
2019
Systemic sclerosis
2017 Standout
The changing landscape of atherosclerosis
2021 StandoutNature
Outcome After Aortic Valve Replacement for Low-Flow/Low-Gradient Aortic Stenosis Without Contractile Reserve on Dobutamine Stress Echocardiography
2009
Pathophysiology and management of multivalvular disease
2016
Management of Mild Aortic Stenosis During Coronary Artery Bypass Surgery:
2003
Exercise testing to stratify risk in aortic stenosis
2005
Outcome of Combined Stenotic and Regurgitant Aortic Valve Disease
2013
Early detection of pulmonary arterial hypertension
2014
16-Detector row computed tomographic coronary angiography in patients undergoing evaluation for aortic valve replacement: comparison with catheter angiography
2006
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
1997 StandoutNature
Hemodynamic Progression and Outcome of Asymptomatic Aortic Stenosis in Primary Care
2011
The Bicuspid Aortic Valve
2005
Growth hormone response to apomorphine, a dopamine receptor agonist, in normal aging and in dementia of the Alzheimer type
1989
Prediction of symptom-onset in aortic stenosis: a comparison of pressure drop/flow slope and haemodynamic measures at rest
2001
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
2009 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
Reduced Efficacy of Growth Hormone-Releasing Hormone in Modulating Sleep Endocrine Activity in the Elderly
1997
Aortic Stenosis
2010
Neuroendocrine control of pulsatile growth hormone release in the human: relationship with gender
1998
Robust Growth Hormone (GH) secretion in aged female rats co-administered GH-releasing hexapeptide (GHRP-6) and GH-releasing hormone (GHRH)
1991
Pulmonary thromboendarterectomy: a clinicopathologic study of 200 consecutive pulmonary thromboendarterectomy cases in one institution
2007
Smooth muscle apoptosis and vascular remodeling
2008
Human Growth Hormone and Human Aging
1993
Four-and-a-Half LIM Domain Proteins Inhibit Transactivation by Hypoxia-inducible Factor 1
2012 StandoutNobel
Aortic Valve Calcification on Computed Tomography Predicts the Severity of Aortic Stenosis
2003
Antibody phage display technology and its applications
1998
Diagnosis and Assessment of Pulmonary Arterial Hypertension
2009
Bicuspid Aortic Valves Are Associated With Aortic Dilatation Out of Proportion to Coexistent Valvular Lesions
2000
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
2008 Standout
Enantioselective Epoxidation of Terminal Alkenes to (R)‐ and (S)‐Epoxides by Engineered Cytochromes P450 BM‐3
2005 StandoutNobel
Outcomes in Moderate Mixed Aortic Valve Disease
2016
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
Late cardiac outcomes after pregnancy in women with congenital aortic stenosis
2009
Defective Hypothalamic Growth Hormone (GH)-Releasing Hormone Activity May Contribute to Declining GH Secretion with Age in Man1
1997
Effects of Iron Supplementation and Depletion on Hypoxic Pulmonary Hypertension
2009 StandoutNobel
Guidelines for Percutaneous Coronary Interventions
2005
Natural History, Diagnostic Approaches, and Therapeutic Strategies for Patients With Asymptomatic Severe Aortic Stenosis
2016
Clinical Outcome in Asymptomatic Severe Aortic Stenosis
2012
Bosentan for chronic thromboembolic pulmonary hypertension: Findings from a systematic review and meta-analysis
2010
Impact of Aortic Valve Calcification, as Measured by MDCT, on Survival in Patients With Aortic Stenosis
2014
When is concomitant aortic valve replacement indicated in patients with mild to moderate stenosis undergoing coronary revascularization?
2005
Cineradiography for determination of normal and abnormal function in mechanical heart valves
1993
Display cloning: functional identification of natural product receptors using cDNA-phage display
1999
Chronic Thromboembolic Pulmonary Hypertension
2001
HIF-1 Regulates Cytochrome Oxidase Subunits to Optimize Efficiency of Respiration in Hypoxic Cells
2007 StandoutNobel
The serum protein α2–Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification
2003 Standout
A Randomized Trial of Intensive Lipid-Lowering Therapy in Calcific Aortic Stenosis
2005 Standout
Initial German Experience With Transapical Implantation of a Second-Generation Transcatheter Heart Valve for the Treatment of Aortic Regurgitation
2014
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
Prognostic value of the pre-transplant diastolic pulmonary artery pressure–to–pulmonary capillary wedge pressure gradient in cardiac transplant recipients with pulmonary hypertension
2013
Medical Therapies for Chronic Thromboembolic Pulmonary Hypertension: An Evolving Treatment Paradigm
2006
Splenectomy and chronic thromboembolic pulmonary hypertension
2005
Perioperative risk of major non-cardiac surgery in patients with severe aortic stenosis: a reappraisal in contemporary practice
2014
Rosuvastatin Affecting Aortic Valve Endothelium to Slow the Progression of Aortic Stenosis
2007
Oxygen Sensing, Homeostasis, and Disease
2011 StandoutNobel
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
2008 Standout
Microvascular disease in chronic thromboembolic pulmonary hypertension: a role for pulmonary veins and systemic vasculature
2014
Risk stratification in asymptomatic moderate to severe aortic stenosis: the importance of the valvular, arterial and ventricular interplay
2010
Mild and moderate aortic stenosis Natural history and risk stratification by echocardiography
2004
Treadmill exercise in apparently asymptomatic patients with moderate or severe aortic stenosis: relationship between cardiac index and revealed symptoms
2010
Measurement of aortic valve calcification using multislice computed tomography: correlation with haemodynamic severity of aortic stenosis and clinical implication for patients with low ejection fraction
2010
Chronic thromboembolic pulmonary hypertension
2014
Outcome of pulmonary endarterectomy in symptomatic chronic thromboembolic disease
2014
Calcific aortic stenosis
2016
Engineered Alkane‐Hydroxylating Cytochrome P450BM3 Exhibiting Nativelike Catalytic Properties
2007 StandoutNobel
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
2007 Standout
Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice
2008
Angiopoietin/Tie2 Pathway Influences Smooth Muscle Hyperplasia in Idiopathic Pulmonary Hypertension
2006
Cyclosporin A Inhibits Hypoxia-induced Pulmonary Hypertension and Right Ventricle Hypertrophy
2006
Thoracic Lymphangiomas, Lymphangiectasis, Lymphangiomatosis, and Lymphatic Dysplasia Syndrome
2000 Standout
Task Force 3: Valvular heart disease
2005
Multimodality Imaging for the Assessment of Severe Aortic Stenosis
2019
Digoxin inhibits development of hypoxic pulmonary hypertension in mice
2012 StandoutNobel
Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human*
1998 Standout
Statins but Not Angiotensin-Converting Enzyme Inhibitors Delay Progression of Aortic Stenosis
2004
The role of chemokines and chemokine receptors in pulmonary arterial hypertension
2019
Predictors of Rapid Progression and Clinical Outcome of Asymptomatic Severe Aortic Stenosis
2016
Pulmonary Vascular Disease in Adults With Congenital Heart Disease
2007
Transcatheter Mitral-Valve Repair in Patients with Heart Failure
2018 Standout
Growth hormone secretion after the administration of GHRP‐6 or GHRH combined with GHRP‐6 does not decline in late adulthood
1995
Oral Rivaroxaban for Symptomatic Venous Thromboembolism
2010 Standout
Pulmonary Arterial Hypertension
2006
An Abnormal Mitochondrial–Hypoxia Inducible Factor-1α–Kv Channel Pathway Disrupts Oxygen Sensing and Triggers Pulmonary Arterial Hypertension in Fawn Hooded Rats
2006
Failure to Prevent Progressive Dilation of Ascending Aorta by Aortic Valve Replacement in Patients With Bicuspid Aortic Valve: Comparison With Tricuspid Aortic Valve
2003
Identification of new genes differentially expressed in coronary artery disease by expression profiling
2003
Pulmonary endarterectomy for chronic thromboembolic disease
2018
Natriuretic Peptides Predict Symptom-Free Survival and Postoperative Outcome in Severe Aortic Stenosis
2004
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Outcome of Patients With Low-Gradient “Severe” Aortic Stenosis and Preserved Ejection Fraction
2011
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Drug Discovery: A Historical Perspective
2000 StandoutScience
Prognostic Importance of Quantitative Exercise Doppler Echocardiography in Asymptomatic Valvular Aortic Stenosis
2005
Bicuspid Aortic Valve
2014
Catalytic Hydroxylation in Biphasic Systems using CYP102A1 Mutants
2005
Sudden Death in Patients With Severe Aortic Stenosis: Observations From the CURRENT AS Registry
2018
Calcific Aortic Valve Disease: Not Simply a Degenerative Process
2011
Chronic Thromboembolic Pulmonary Hypertension
2006 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Current Management of Calcific Aortic Stenosis
2013
Endothelial Hypoxia-Inducible Factor-2α Is Required for the Maintenance of Airway Microvasculature
2019 StandoutNobel
Spectrum of Calcific Aortic Valve Disease
2005
Printing Proteins as Microarrays for High-Throughput Function Determination
2000 StandoutScience
Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses.
1994
Outcome of 622 Adults With Asymptomatic, Hemodynamically Significant Aortic Stenosis During Prolonged Follow-Up
2005
Contemporary natural history of bicuspid aortic valve disease: a systematic review
2017
Sex differences in growth hormone response to growth hormone-releasing hormone
1991
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
2009 Standout
Effect of Hydroxymethylglutaryl Coenzyme A Reductase Inhibitors on the Progression of Calcific Aortic Stenosis
2001
Progression of Aortic Valve Calcification
2001
Fhl-1, a New Key Protein in Pulmonary Hypertension
2008
Pregnancy outcomes in women with significant valve disease: a systematic review and meta-analysis
2020
Diagnostic Evaluation and Management of Chronic Thromboembolic Pulmonary Hypertension: A Clinical Practice Guideline
2010
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Addition of Sildenafil to Long-Term Intravenous Epoprostenol Therapy in Patients with Pulmonary Arterial Hypertension
2008
Natural History of Very Severe Aortic Stenosis
2009
Evaluation and Clinical Implications of Aortic Valve Calcification Measured by Electron-Beam Computed Tomography
2004
IL-32 Promotes Angiogenesis
2013
Acute Coronary Syndromes
2017
Hypoxia-inducible factor 1 transcriptional activity in endothelial cells is required for acute phase cardioprotection induced by ischemic preconditioning
2012 StandoutNobel
Increased Plasma Natriuretic Peptide Levels Reflect Symptom Onset in Aortic Stenosis
2003
Potential Causality and Emerging Medical Therapies for Lipoprotein(a) and Its Associated Oxidized Phospholipids in Calcific Aortic Valve Stenosis
2019
Abnormal Extracellular Matrix Protein Transport Associated With Increased Apoptosis of Vascular Smooth Muscle Cells in Marfan Syndrome and Bicuspid Aortic Valve Thoracic Aortic Aneurysm
2003
Works of Iréne Lang being referenced
Expression of type 1 plasminogen activator inhibitor in chronic pulmonary thromboemboli.
1994
Unilateral Chronic Thromboembolic Pulmonary Disease Associated With Combined Inherited Thrombophilia
2002
Coronary Neutrophil Extracellular Trap Burden and Deoxyribonuclease Activity in ST-Elevation Acute Coronary Syndrome Are Predictors of ST-Segment Resolution and Infarct Size
2014
Recombinant rabbit Fab with binding activity to type-1 plasminogen activator inhibitor derived from a phage-display library against human α-granules
1996
Pulmonary Artery Thromboendarterectomy: A Comparison of Two Different Postoperative Treatment Strategies
2000
Selexipag for the Treatment of Pulmonary Arterial Hypertension
2015
Predictors of Outcome in Severe, Asymptomatic Aortic Stenosis
2000
Longitudinal analysis of perfusion lung scintigrams of patients with unoperated chronic thromboembolic pulmonary hypertension
2004
Chronic Thromboembolic Pulmonary Hypertension
2013
The Influence of Age on Human Pancreatic Growth Hormone Releasing Hormone Stimulated Growth Hormone Secretion
1988
Increased intimal apoptosis in coronary atherosclerotic vessel segments lacking compensatory enlargement
2001
Selexipag: an oral, selective prostacyclin receptor agonist for the treatment of pulmonary arterial hypertension
2012
The efficacy of bosentan in inoperable chronic thromboembolic pulmonary hypertension: a 1-year follow-up study
2006
Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding
2012
Vascular and right ventricular remodelling in chronic thromboembolic pulmonary hypertension
2012
Interventional and surgical modalities of treatment for pulmonary arterial hypertension
2004
Bosentan for Treatment of Inoperable Chronic Thromboembolic Pulmonary Hypertension
2008
Right Ventricular Load at Exercise Is a Cause of Persistent Exercise Limitation in Patients With Normal Resting Pulmonary Vascular Resistance After Pulmonary Endarterectomy
2010
Cellular and molecular pathobiology of pulmonary arterial hypertension
2004 Standout
2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy
2019
Circulating microparticles carry oxidation-specific epitopes and are recognized by natural IgM antibodies
2014
Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension
2017
Coupling of Biocatalytic Asymmetric Epoxidation with NADH Regeneration in Organic–Aqueous Emulsions
2004
Comprehensive analysis of inflammatory markers in chronic thromboembolic pulmonary hypertension patients
2014
Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: Results from an international prospective registry
2011
Bosentan Therapy for Inoperable Chronic Thromboembolic Pulmonary Hypertension
2005
Risk factors for chronic thromboembolic pulmonary hypertension
2012
Fibrinolytic Balance of the Arterial Wall: Pulmonary Artery Displays Increased Fibrinolytic Potential Compared with Aorta
2003
Asymmetric Dimethylarginine Is Increased in Chronic Thromboembolic Pulmonary Hypertension
2007
Long-term treatment of pulmonary hypertension with aerosolized iloprost
2000
Risk factors for chronic thromboembolic pulmonary hypertension
2008
Diagnosis, Assessment, and Treatment of Non-Pulmonary Arterial Hypertension Pulmonary Hypertension
2009
Medical conditions increasing the risk of chronic thromboembolic pulmonary hypertension
2005
High prevalence of elevated clotting factor VIII in chronic thromboembolic pulmonary hypertension
2003
Angiostatic Factors in the Pulmonary Endarterectomy Material from Chronic Thromboembolic Pulmonary Hypertension Patients Cause Endothelial Dysfunction
2012
Treprostinil for severe inoperable chronic thromboembolic pulmonary hypertension
2007
Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel
2008
Surgical specimens, haemodynamics and long-term outcomes after pulmonary endarterectomy
2013
Interventional and Surgical Modalities of Treatment in Pulmonary Hypertension
2009
Purification of Storage Granule Protein-23
1996
Risk Factors for Chronic Thromboembolic Pulmonary Hypertension
2006
Efficacy of Long-term Subcutaneous Treprostinil Sodium Therapy in Pulmonary Hypertension
2006
Refining the prognostic impact of functional mitral regurgitation in chronic heart failure
2017
Pulmonary hypertension due to left heart disease
2018
Imaging in Pulmonary Hypertension
2010
Defective Angiogenesis Delays Thrombus Resolution
2014
[Chronic thromboembolic pulmonary hypertension and its treatment with pulmonary thrombendarterectomy].
1995
Parallel analysis of tissue-type plasminogen activator and type 1 plasminogen activator inhibitor in plasma and endothelial cells derived from patients with chronic pulmonary thromboemboli.
1994
Pulmonary Vascular Reactivity and Prognosis in Patients With Chronic Thromboembolic Pulmonary Hypertension
2009
Expression of the Angiogenic Protein, Platelet-Derived Endothelial Cell Growth Factor, in Coronary Atherosclerotic Plaques
1999
Left Main Coronary Artery Compression by the Pulmonary Trunk in Pulmonary Hypertension
2002
Factors contributing to increased vascular fibrinolytic activity in mongrel dogs.
1993
Effects of Sex and Age on Growth Hormone Response to Growth Hormone-Releasing Hormone in Healthy Individuals
1987
Update on Chronic Thromboembolic Pulmonary Hypertension
2014
A novel therapeutic strategy for the management of idiopathic chylopericardium and chylothorax
1998
Four year follow-up of the Duromedics Edwards bileaflet valve prostheses.
1990
Plasma Lp(a) Levels Are Increased in Patients with Chronic Thromboembolic Pulmonary Hypertension
1998
Expression of Kunitz Protease Inhibitor–Containing Forms of Amyloid β-Protein Precursor Within Vascular Thrombi
1996
Elevated Expression of Urokinase-like Plasminogen Activator and Plasminogen Activator Inhibitor Type 1 During the Vascular Remodeling Associated With Pulmonary Thromboembolism
1998
Coronary no-reflow is caused by shedding of active tissue factor from dissected atherosclerotic plaque
2002
Heart-type fatty acid-binding protein for risk assessment of chronic thromboembolic pulmonary hypertension
2008
Three-Dimensional Visualization of Pulmonary Thromboemboli in Chronic Thromboembolic Pulmonary Hypertension With Multiple Detector-Row Spiral Computed Tomography
2001
Normal values for Doppler echocardiographic assessment of prosthetic valve function after transcatheter aortic valve replacement: a systematic review and meta-analysis
2017
Biokatalytische asymmetrische Epoxidierung kombiniert mit NADH‐Regenerierung in organisch‐wässrigen Emulsionen
2004
Suppression of thrombolysis in a canine model of pulmonary embolism.
1994
Mechanisms Underlying Aortic Dilatation in Congenital Aortic Valve Malformation
1999
Intracoronary Thrombectomy With the X-Sizer Catheter System Improves Epicardial Flow and Accelerates ST-Segment Resolution in Patients With Acute Coronary Syndrome
2002
Role for Staphylococci in Misguided Thrombus Resolution of Chronic Thromboembolic Pulmonary Hypertension
2008
Diastolic Pulmonary Vascular Pressure Gradient
2013
Abnormalities in the Hypothalamic-Pituitary-Adrenocortical Axis in Patients With Chronic Renal Failure
1987
Endogenous fibrinolytic system in chronic large-vessel thromboembolic pulmonary hypertension.
1992
Predictors of Outcome in Chronic Thromboembolic Pulmonary Hypertension
2007